Pathophysiological effects of aldosterone in cardiovascular tissues (Q34336943)

1 August 2017

1 reference

title

Pathophysiological effects of aldosterone in cardiovascular tissues (English)

1 reference

1 August 2017

1 reference

1 reference

Rocha R

1

1 reference

PubMed ID

11504670

1 August 2017

Stier CT Jr

series ordinal

2

1 reference

1 August 2017

1 September 2001

1 reference

Trends in Endocrinology and Metabolism

1 August 2017

1 reference

1 August 2017

12

1 reference

1 August 2017

7

1 reference

1 August 2017

308-314

1 reference

Essential hypertension: renin and aldosterone, heart attack and stroke.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Pathologic consequences of increased angiotensin II activity

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

11 beta-Hydroxysteroid dehydrogenase: new answers, new questions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Glucocorticoid receptor, mineralocorticoid receptors, 11 beta-hydroxysteroid dehydrogenase-1 and -2 expression in rat brain and kidney: in situ studies

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Vascular aldosterone in genetically hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Hyperaldosteronemia in rabbits inhibits the cardiac sarcolemmal Na(+)-K(+) pump

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Effects of aldosterone and spironolactone on the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Aldosterone upregulates Ca(2+) current in adult rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Heat shock proteins 70 and 90 increase calcineurin activity in vitro through calmodulin-dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

THE PRODUCTION OF CARDIAC LESIONS BY REPEATED INJECTIONS OF DESOXYCORTICOSTERONE ACETATE.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Complete prevention of cerebral accidents in malignant hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Role of aldosterone in the remnant kidney model in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Left ventricular fibrosis in renovascular hypertensive rats. Effect of losartan and spironolactone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Biological determinants of aldosterone-induced cardiac fibrosis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Aldosterone and cardiac fibrosis: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Does Aldosterone-lnduced Cardiac Fibrosis Involve Direct Effects on Cardiac Fibroblasts?

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Plasma aldosterone concentrations in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Primary aldosteronism and its variants

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Cardiovascular complications in patients with primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Changes in left ventricular anatomy and function in hypertension and primary aldosteronism.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2801%2900432-5

7 January 2021

10.1016/S1043-2760(01)00432-5

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11504670